Drug intelligence / Profile preview

amphotericin B phosphatidylglycerol complex liposome

Development stage
Phase 1
Lead developer
Beijing Tide Pharmaceutical
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Amphotericin B phosphatidylglycerol complex liposome is an investigational liposomal formulation of the polyene antifungal amphotericin B, developed by Beijing Tide Pharmaceutical. The drug functions by binding to ergosterol, a key component of fungal cell membranes, which leads to the formation of transmembrane pores. These pores cause the leakage of essential intracellular ions and molecules, ultimately resulting in fungal cell death. This specific formulation utilizes a phosphatidylglycerol complex within a liposomal structure to optimize the pharmacokinetic profile and reduce the nephrotoxicity typically associated with conventional amphotericin B deoxycholate. It is being evaluated in clinical trials for the treatment of systemic fungal infections, leishmaniasis, and as empirical therapy for suspected fungal infections in patients with febrile neutropenia.

Other names
amphotericin B phosphatidylglycerol complex liposome injectionamphotericin B liposome
02

Targets

Ergosterol

Beyond the preview

Go deeper on amphotericin B phosphatidylglycerol complex liposome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amphotericin B phosphatidylglycerol complex liposome.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call